Lenny Santoro was diagnosed with prostate cancer in 2011. Thanks to clinical trials Santoro participated in at the Duke ...

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

Hinterhaus Productions via Getty Images Shares of Edgewise Therapeutics fell sharply Wednesday after the company released data for its latest clinical trial. The drug accomplished its main goal ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

A new AI tool could slash cancer drug research waiting times in half - AI technology developed by a team at The Institute of ...

Shares of Edgewise Therapeutics fell sharply Wednesday after the company released data for its latest clinical trial. The drug accomplished its main goal, but side effects reported by some ...

One in 6 patients in phase 2 cancer trials received treatments that were eventually approved by the US Food and Drug Administration (FDA), a new analysis found. This proportion increased to 1 in 5 ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will prevent heart attacks and strokes. By Gina Kolata As many as one in five ...

Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial. Novo's results from its Redefine 2 late-stage trial of ...

The drug also reduced systolic blood pressure by 7.9 mmHg in a mid-stage trial, in adults who had high-blood pressure despite taking at least two other medications for the symptoms, the company said.

Findings from an earlier trial of the Eli Lilly drug, called lepodisiran, showed the drug was safe. The latest study, a Phase 2 clinical trial funded by Lilly, included 320 people. One injection ...